Surveillance for Pneumococcal Disease in the United States by Cynthia G Whitney

Get full text

Forecasting Trends in Invasive Pneumococcal Disease among Elderly Adults in Quebec by Z. Zhou, G. Deceuninck, B. Lefebvre, P. De Wals

“…Methods. Invasive pneumococcal disease (IPD) cases in adults 65–74 years of age in the Quebec notifiable diseases registry were classified into five serotype categories. …”
Get full text

Hospital burden of pneumococcal disease in Spain (2016–2022): A retrospective study by Ruth Gil-Prieto, Valentín Hernandez-Barrera, Patricia Marín-García, Alba González-Escalada, Ángel Gil-de-Miguel

Subjects: Get full text

Estimation of invasive pneumococcal disease dynamics parameters and the impact of conjugate vaccination in Australia by Karyn L. Sutton, H.T. Banks, Carlos Castillo-Chávez

“…Pneumococcal diseases, or infections from the etiological agent Streptococcus pneumoniae, have long been a major cause of morbidity andmortality worldwide. …”
Get full text

Clinical Features and Outcomes of Serotype 19A Invasive Pneumococcal Disease in Calgary, Alberta by Leah J Ricketson, Otto G Vanderkooi, Melissa L Wood, Jenine Leal, James D Kellner

“…BACKGROUND: Streptoccocus pneumoniae serotype 19A (ST19A) became an important cause of invasive pneumococcal disease (IPD) after the introduction of the conjugate vaccine.…”
Get full text

Impact of invasive and noninvasive pneumococcal diseases on adult populations: risk factors and vaccination status by Hasip Kahraman, Pınar Yıldız, Şenay Yılmaz, Gül Durmaz, Muzaffer Bilgin, Derya Çağlayan

Subjects: Get full text

Preventing Pneumococcal Disease: A Canadian Consensus Conference, February 16 to 18, 1998

Get full text

Overview of Community-Acquired Pneumonia and the Role of Inflammatory Mechanisms in the Immunopathogenesis of Severe Pneumococcal Disease by Helen C. Steel, Riana Cockeran, Ronald Anderson, Charles Feldman

Get full text

How Many Individuals with Asthma Need to Be Vaccinated to Prevent One Case of Invasive Pneumococcal Disease? by Julie M Okapuu, Estelle Chétrit, Brigitte Lefebvre, Caroline Quach

“…BACKGROUND: The American Advisory Committee on Immunization Practices recommended the inclusion of adults with asthma in the high-risk category for pneumococcal vaccination based on a twofold increase in risk of invasive pneumococcal disease (IPD).…”
Get full text

Invasive Pneumococcal Disease: Still Lots to Learn and a Need for Standardized Data Collection Instruments by T. J. Marrie, G. J. Tyrrell, Sumit R. Majumdar, Dean T. Eurich

“…Large studies of invasive pneumococcal disease (IPD) are frequently lacking detailed clinical information. …”
Get full text

Temporal Variations among Invasive Pneumococcal Disease Serotypes in Children and Adults in Germany (1992–2008) by Matthias Imöhl, Ralf René Reinert, Mark van der Linden

“…Nationwide surveillance of invasive pneumococcal disease has been conducted in Germany since 1992. …”
Get full text

Treated Follicular Lymphoma, Recurrent Invasive Pneumococcal Disease, Nonresponsiveness to Vaccination, and a Unique Pneumococcus by Clare Murphy, Donald Inverarity, Claire McGoldrick, Lindsay Mitchell, Pamela Paterson, Louise Thom, Giles Edwards

Get full text

Assessing the Potential Impact of Vaccination Programs on Invasive Pneumococcal Disease: Data from Population-Based Surveillance by Allison McGeer, Karen Green, Lisa Landry, James Talbot, Ellie Goldenberg, The Toronto Invasive Bacterial Diseases Network

Get full text

Hospitalization due to pneumococcal disease in the Unified Health System in Brazil: A retrospective analysis of administrative data by Daniela V. Pachito, Mauricio Longato, Guilherme Cordeiro, Paulo H.R.F. Almeida, Ricardo Macarini Ferreira, Ana Paula N. Burian

“…Introduction: Community-Acquired Pneumonia (CAP) caused by pneumococcus and Invasive Pneumococcal Disease (IPD) pose a substantial economic burden on health systems. …”
Get full text

Serotype-specific serum immunoglobulin G at 18 months of age following one or two doses of a primary series of 10-valent or 13-valent pneumococcal conjugate vaccine and a booster d... by Alane Izu, Eleanora Aml Mutsaerts, Courtney Olwagen, Lisa Jose, Anthonet Koen, Amit J Nana, Clare L. Cutland, Shabir A. Madhi

Subjects: Get full text

IAPSM’s Position Paper on Pneumococcal Vaccine (PCV) for Adult Immunization in India by Chythra R. Rao, Veena G. Kamath, Anuradha Nadda, Swayam P. Parida, Nikita Sharma, Kapil Goel, Ranjitha S. Shetty, Madhur Verma, Arvind Kumar Singh, Abhisek Mishra, Swosti Kiran, Lalit Sankhe, Madhu Gupta

Subjects: Get full text

A population-based study on the burden of hospitalized pediatric pneumococcal disease in Taiwan before and after the introduction of 13-valent pneumococcal conjugate vaccine into the childhood immunization program in 2015 by Ting-An Yen, Jhong-Lin Wu, Chi-Chuan Wang, Ling-Ya Huang, See-Hwee Yeo, Dony Patel, Cindy Thiow Koon Lim, Hung-Wei Lin, Eriko Yamada, Isaya Sukarom

Subjects: Get full text

Multiple viral infections and antimicrobial use in hospitalized children with respiratory illness during pandemic and early post-pandemic era, Taiwan by Chyi-Liang Chen, Yi-Ching Chen, Hsuan-Ling Hsiao, Yi-Jung Chang, Hsin-Chieh Li, Merve Arslan Aydin, Cheng-Hsun Chiu

Subjects: Get full text

Economic evaluation of childhood pneumococcal conjugate vaccination programs in Qinghai and Hainan provinces, China by Haonan Zhang, Chaofan Wang, Haijun Zhang, Brian Wahl, Maria Deloria Knoll, Xiaozhen Lai, Hai Fang

Subjects: “…Pneumococcal disease…”
Get full text

A large-scale risk assessment and classification model for pneumococcus using Finnish national health data by Viljami Männikkö, Juha Turunen, Heidi Åhman, Esa Harju

“…We analyzed health data from 96,200 Finnish residents with risk factors for pneumococcal disease following guidelines from the Finnish Institute for Health and Welfare and the World Health Organization. …”
Get full text